Opportunities and challenges for cancer immunotherapy based on antigen cross-presentation
Deep insight of XPT in DCs and its affecting factors in tumor immunology will hopefully lead to better therapeutic translation in clinical treatment of tumor, the fatal disease that has threatened human life for centuries.
Authors
- Zhe Zhou (ORCID: https://orcid.org/0000-0002-2898-7340)
- Xia Su (ORCID: https://orcid.org/0009-0008-1628-8199)
- Jinyao Li
- Peng Liu
- Yuekang Xu
Institutions
- Xinjiang University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-02-27
- DOI
- https://doi.org/10.1080/07853890.2026.2635774
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00